Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 1:02 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 197 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Desensitization Therapy Clear all

Conditions: Kidney Transplantation in Highly Sensitized Patients
Interventions: Imlifidase, PLEX, IVIg, Anti-CD20 antibodies, Eculizumab, Remain on wait list; Drug · Procedure · Other
Lead sponsor: Hansa Biopharma AB; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 25
States / cities: Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 16 more

Conditions: Infertility
Interventions: Healing Touch, Desensitization Therapy; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 42 Years · Female only
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Stanford, California

Conditions: Anxiety Disorders in Youth With Autism, Asperger's Syndrome, and Pervasive Developmental Disorder Not Otherwise Specified
Interventions: Cognitive-Behavioral Therapy, Wait-list; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 11 Years to 14 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2014
U.S. locations: 2
States / cities: Los Angeles, California • St. Petersburg, Florida

Conditions: Allergic Asthma, Allergic Rhinitis
Interventions: Allergen immunotherapy; Biological
Lead sponsor: Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Bryn Mawr, Pennsylvania

Conditions: Stress Disorders, Post-Traumatic Stress Disorder
Interventions: Prolonged Exposure Therapy (PE), Virtual Reality Exposure Therapy (VRET), Waitlist; Behavioral
Lead sponsor: National Center for Telehealth and Technology; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Fort Bragg, North Carolina

Conditions: Transplants and Implants
Interventions: plerixafor, Bortezomib, plasmapheresis; Drug · Other
Lead sponsor: E. Steve Woodle; Other
Eligibility: 18 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 2
States / cities: Cincinnati, Ohio

Conditions: Phenylketonuria, PKU
Interventions: RDD to Palynziq; Drug
Lead sponsor: BioMarin Pharmaceutical; Industry
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Chevy Chase, Maryland

Conditions: Needle Phobia, Virtual Reality, Cognitive Behavior Treatment
Interventions: Mixed reality (XR) Exposure Therapy; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 11 Years to 17 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: Sexual Dysfunction, Pelvic Floor Disorders, Gynecologic Cancer
Interventions: Integrated Physical Therapy and Coping Skills Training; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Nightmares, Insomnia, Posttraumatic Stress Disorder
Interventions: PTSD + IRT/CBT-I, PTSD + Supportive Care Therapy; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: San Diego, California

Conditions: HLA Sensitization
Interventions: plasmapheresis, Bortezomib, Rituximab, Methylprednisolone; Drug
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years to 65 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 2
States / cities: Cincinnati, Ohio

Conditions: Peanut Allergy
Interventions: AR101 powder provided in capsules, Placebo powder provided in capsules; Biological
Lead sponsor: Aimmune Therapeutics, Inc.; Industry
Eligibility: 4 Years to 26 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 8
States / cities: Little Rock, Arkansas • San Diego, California • Boston, Massachusetts + 5 more

Conditions: Food Allergy
Interventions: Egg Oral Immunotherapy, Baked Egg; Drug
Lead sponsor: Hugh A Sampson, MD; Other
Eligibility: 3 Years to 16 Years
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 5
States / cities: Little Rock, Arkansas • Denver, Colorado • Baltimore, Maryland + 2 more

Conditions: Persistent Postural Perceptual Dizziness, Vestibular Migraine, Chronic Dizziness
Interventions: Virtual Reality; Device
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 13 Years to 25 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Waltham, Massachusetts

Conditions: Ischemic Stroke, Intra Cerebral Hemorrhage, Obstructive Sleep Apnea, Adherence, Treatment, Motivation
Interventions: Continuous positive airway pressure (CPAP), CPAP technical support intervention, Motivational Enhancement Therapy (MET), Mobile Health intervention; Device · Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Specific Phobia
Interventions: Exposure therapy; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Specific Phobia, Anxiety Disorders, Fear of Heights, Acrophobia
Interventions: Virtual Reality Exposure Therapy, Tactile Feedback, Point-based Rewards; Behavioral
Lead sponsor: University of Nevada, Reno; Other
Eligibility: 18 Years and older
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Reno, Nevada

Conditions: Phobic Disorders, Dental Anxiety, Treatment Outcome
Interventions: Exposure Therapy; Behavioral
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Fear of Flying
Interventions: Virtual Reality Exposure Therapy; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 89 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Kidney Transplantation in Highly Sensitized Patients
Interventions: Imlifidase administered in the ConfIdeS study, Best available treatment administered in the ConfIdeS study; Drug · Other
Lead sponsor: Hansa Biopharma AB; Industry
Eligibility: Not listed
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 14
States / cities: Birmingham, Alabama • Los Angeles, California • Chicago, Illinois + 9 more

Conditions: Patients With AERD Undergoing Aspirin Desensitization
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Allergic Rhinitis Due to Tree Pollen, Allergic Conjunctivitis, Allergic Rhinoconjunctivitis
Interventions: Intra-lymphatic allergenic extract, Intra-lymphatic placebo; Biological
Lead sponsor: Christopher Thompson, MD; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 3
States / cities: Austin, Texas • Grapevine, Texas • San Antonio, Texas

Conditions: Grief, Depressive Symptoms, Trauma, Psychological
Interventions: Accelerated Resolution Therapy; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 60 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Kidney Failure
Interventions: IVIg and rituximab; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx

Stress Reduction During In Vitro Fertilization

Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents

The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis

Comparing Virtual Reality Exposure Therapy to Prolonged Exposure

Quantitating the Impact of Plerixafor

Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to Palynziq

Use of Augmented Reality and Virtual Reality During Cognitive Behavioral Therapy for Needle Phobia

Improving Women's Function After Pelvic Radiation

Treating Insomnia & Nightmares After Trauma: Impact on Symptoms & Quality of Life

Desensitization in Kidney Transplantation

Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT

Baked Egg or Egg Oral Immunotherapy for Children With Egg Allergy

Virtual Reality and Biofeedback for Adolescents With Chronic Dizziness

Stroke and CPAP Outcome Study 3

The Effects of Safety Seeking Behaviors During Exposure Therapy for Adults With Spider Phobia

Augmenting Virtual Reality Exposure Therapy for Acrophobia

Smartphone-Based Exposure Treatment for Dental Anxiety

Targeting Reconsolidation to Prevent Return of Fear

Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys

The Metabolomics of Anaphylaxis

Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study

Accelerated Resolution Therapy for Complicated Grief

Desensitization of Highly Sensitized Deceased Donor Renal Transplantation Candidates